Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | AMGN | GILD | CELG | ILMN |
| Company | Lexicon Pharmaceutcl | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6300 | 264.63 | 66.25 | 108.01 | 117.69 |
| High | 1.6900 | 269.38 | 66.83 | 108.59 | 119.22 |
| Low | 1.6000 | 260.68 | 66.16 | 107.27 | 116.61 |
| Last | 1.6500 | 268.93 | 66.76 | 108.24 | 117.43 |
| Change | +0.0200 | +6.18 | +0.60 | +0.11 | +0.74 |
| % Change | +1.23% | +2.35% | +0.91% | +0.10% | +0.63% |
| Volume | 2,951,942 | 3,375,252 | 10,656,155 | 191,230,496 | 1,399,115 |
| 20-Day Average Volume | 3,282,062 | 2,246,183 | 6,455,878 | 16,188,930 | 1,498,556 |
| Previous Close | 1.6300 | 262.75 | 66.16 | 108.13 | 116.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0122 | 272.56 | 69.90 | 108.17 | 128.39 |
| 20-Day Raw Stochastic | 5.75% | 29.59% | 10.79% | 63.25% | 6.98% |
| 20-Day Relative Strength | 38.33% | 43.95% | 31.30% | 64.69% | 36.48% |
| Weighted Alpha | -51.47 | +7.67 | -24.32 | +46.30 | -45.51 |
| Today's Opinion | 8% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Previous Opinion | 8% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 72% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.24% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -1.97% since 11/13/19 | -7.59% since 04/12/24 |
| Low | 1.6000 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 115.73 on 04/18/24 |
| High | 1.9600 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 128.28 on 04/15/24 |
| 1-Month | |||||
| %Chg | -32.38% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | +5.14% since 10/18/19 | -11.81% since 03/19/24 |
| Low | 1.6000 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 2.5900 on 03/21/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | +26.92% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | +13.63% since 08/20/19 | -13.58% since 01/19/24 |
| Low | 1.2900 on 01/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 3.7300 on 02/16/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +42.86% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +14.14% since 05/20/19 | -2.13% since 10/19/23 |
| Low | 0.9200 on 11/10/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 3.7300 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 401,366 | 140,812,720 | 82,374,304 | 77,035,920 | 18,583,468 |
| Shares Outstanding, K | 246,237 | 535,919 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 1,200,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -177,120,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 700,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -49,760,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 1.27 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 03/11/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 135.97 |